David R. Light

Also affiliated with Sanofi (United States), Chrysalis BioTherapeutics (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease”.

MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease

Blood Advances(2021)10.1182/bloodadvances.2020003670

N/A

0DataRank · unranked

9 citations

Sarah Sturtevant, Kevin R. Guertin, Dipti Gupta, Kunal Desai, Benjamin Vieira +13 more